Compensatory erythropoiesis has no impact on the outcome of the in vivo Pig-a mutation assay in rats following treatment with the haemolytic agent 2-butoxyethanol

Mutagenesis

Volumn 30, Issue 3, 2015, Pages 325-334

  Kenyon, Michelle O ^a   Coffing, Stephanie L ^a   Ackerman, Joel I ^a   Gunther, William C ^a   Dertinger, Stephen D ^b   Criswell, Kay ^a   Dobo, Krista L ^a  

^a PFIZER INC   (United States)

^b LITRON LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 BUTOXYETHANOL; ETHYLENE GLYCOL DERIVATIVE; HEMOLYTIC AGENT; MEMBRANE PROTEIN; MUTAGENIC AGENT; N-BUTOXYETHANOL; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROPOIESIS; FEEDING; GENE MUTATION; HEMATOLOGICAL PARAMETERS; IN VIVO STUDY; LYSIS; MALE; MUTAGENICITY; MUTANT; NONHUMAN; PHENOTYPE; PIG A MUTATION ASSAY; PRIORITY JOURNAL; RAT; RETICULOCYTE; ANIMAL; DNA MUTATIONAL ANALYSIS; DRUG EFFECTS; GENETICS; MUTAGEN TESTING; MUTAGENESIS; MUTATION; REPORTER GENE; WISTAR RAT;

RATTUS; SUIDAE;

ANIMALS; DNA MUTATIONAL ANALYSIS; ERYTHROPOIESIS; ETHYLENE GLYCOLS; GENES, REPORTER; HEMOLYTIC AGENTS; MALE; MEMBRANE PROTEINS; MUTAGENESIS; MUTAGENICITY TESTS; MUTAGENS; MUTATION; RATS, WISTAR; RETICULOCYTES;

EID: 84929575274     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geu051     Document Type: Article

References (31)

1. Bryce, S. M., Bemis, J. C. and Dertinger, S. D. (2008) In vivo mutation assay based on the endogenous Pig-A locus. Environ. Mol. Mutagen., 49, 256-264.
2. Miura, D., Dobrovolsky, V. N., Kasahara, Y., Katsuura, Y. and Heflich, R. H. (2008) Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ. Mol. Mutagen., 49, 614-621.
3. Miura, D., Dobrovolsky, V. N., Mittelstaedt, R. A., Kasahara, Y., Katsuura, Y. and Heflich, R. H. (2008) Development of an in vivo gene mutation assay using the endogenous Pig-A gene: II. Selection of Pig-A mutant rat spleen T-cells with proaerolysin and sequencing Pig-A cDNA from the mutants. Environ. Mol. Mutagen., 49, 622-630.
4. Phonethepswath, S., Bryce, S. M., Bemis, J. C. and Dertinger, S. D. (2008) Erythrocyte-based Pig-A gene mutation assay: demonstration of cross-species potential. Mutat. Res., 657, 122-126.
5. Schuler, M., Gollapudi, B. B., Thybaud, V. and Kim, J. H. (2011) Need and potential value of the Pig-ain vivo mutation assay-A HESI perspective. Environ. Mol. Mutagen., 52, 685-689.
6. Bhalli, J. A., Ding, W., Shaddock, J. G., Pearce, M. G., Dobrovolsky, V. N. and Heflich, R. H. (2013) Evaluating the weak in vivo micronucleus response of a genotoxic carcinogen, aristolochic acids. Mutat. Res., 753, 82-92.
7. Cammerer, Z., Bhalli, J. A., Cao, X. et al. (2011) Report on stage III Pig-A mutation assays using N-ethyl-N-nitrosourea-comparison with other in vivo genotoxicity endpoints. Environ. Mol. Mutagen., 52, 721-730.
8. Dertinger, S. D., Phonethepswath, S., Avlasevich, S. L. et al. (2012) Efficient monitoring of in vivo pig-A gene mutation and chromosomal damage: summary of 7 published studies and results from 11 new reference compounds. Toxicol. Sci., 130, 328-348.
9. Dertinger, S. D., Phonethepswath, S., Franklin, D. et al. (2010) Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol. Sci., 115, 401-411.
10. Dobo, K. L., Fiedler, R. D., Gunther, W. C., Thiffeault, C. J., Cammerer, Z., Coffing, S. L., Shutsky, T. and Schuler, M. (2011) Defining EMS and ENU dose-response relationships using the Pig-A mutation assay in rats. Mutat. Res., 725, 13-21.
11. Gollapudi, B. B., Lynch, A. M., Heflich, R. H. et al. (2014) The in vivo Pig-A assay: A report of the International Workshop on Genotoxicity Testing (IWGT) Workgroup. Mutat. Res. 2014 September 26 [Epub ahead of print], doi:10.1016/j.mrgentox.2014.09.007.
12. Olver, C.S. (2010) Erythropoiesis. In Weiss, D. J., Jane Wardrop, K. (eds), Schalm's Veterinary Hematology. 6th ed. Wiley-Blackwell, Ames, IA, pp. 36-42.
13. Rosti, V., Tremml, G., Soares, V., Pandolfi, P. P., Luzzatto, L. and Bessler, M. (1997) Murine embryonic stem cells without pig-A gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J. Clin. Invest., 100, 1028-1036.
14. Araten, D. J., Bessler, M., McKenzie, S., Castro-Malaspina, H., Childs, B. H., Boulad, F., Karadimitris, A., Notaro, R. and Luzzatto, L. (2002) Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia, 16, 2243-2248.
15. Heddle, J. A. (1999) On clonal expansion and its effects on mutant frequencies, mutation spectra and statistics for somatic mutations in vivo. Mutagenesis, 14, 257-260.
16. Elliott, B. M. and Ashby, J. (1997) Review of the genotoxicity of 2-butoxyethanol. Mutat. Res., 387, 89-96.
17. Ghanayem, B. I. and Sullivan, C. A. (1993) Assessment of the haemolytic activity of 2-butoxyethanol and its major metabolite, butoxyacetic acid, in various mammals including humans. Hum. Exp. Toxicol., 12, 305-311.
18. Ezov, N., Levin-Harrus, T., Mittelman, M. et al. (2002) A chemically induced rat model of hemolysis with disseminated thrombosis. Cardiovasc. Toxicol., 2, 181-194.
19. Fastier, A., Herve-Bazin, B. and McGregor, D. B. (2005) INRS activities on risk assessment of glycol ethers. Toxicol. Lett., 156, 59-76.
20. Dertinger, S. D., Bryce, S. M., Phonethepswath, S. and Avlasevich, S. L. (2011) When pigs fly: immunomagnetic separation facilitates rapid determination of Pig-A mutant frequency by flow cytometric analysis. Mutat. Res., 721, 163-170.
21. Ghanayem, B. I., Long, P. H., Ward, S. M., Chanas, B., Nyska, M. and Nyska, A. (2001) Hemolytic anemia, thrombosis, and infarction in male and female F344 rats following gavage exposure to 2-butoxyethanol. Exp. Toxicol. Pathol., 53, 97-105.
22. Ghanayem, B. I., Sanchez, I. M. and Matthews, H. B. (1992) Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms. Toxicol. Appl. Pharmacol., 112, 198-206.
23. Ghanayem, B. I., Ward, S. M., Blair, P. C. and Matthews, H. B. (1990) Comparison of the hematologic effects of 2-butoxyethanol using two types of hematology analyzers. Toxicol. Appl. Pharmacol., 106, 341-345.
24. Ghanayem, B. I., Ward, S. M., Chanas, B. and Nyska, A. (2000) Comparison of the acute hematotoxicity of 2-butoxyethanol in male and female F344 rats. Hum. Exp. Toxicol., 19, 185-192.
25. Udden, M. M. (2000) Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: A comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes. J. Appl. Toxicol., 20, 381-387.
26. Ghanayem, B. I., Burka, L. T. and Matthews, H. B. (1987) Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases. J. Pharmacol. Exp. Ther., 242, 222-231.
27. Miura, D., Dobrovolsky, V. N., Kimoto, T., Kasahara, Y. and Heflich, R. H. (2009) Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat. Res., 677, 86-92.
28. Phonethepswath, S., Franklin, D., Torous, D. K. et al. (2010) Pig-A mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol. Sci., 114, 59-70.
29. Sivarao, D. V. and Mehendale, H. M. (1995) 2-Butoxyethanol autoprotection is due to resiliance of newly formed erythrocytes to hemolysis. Arch. Toxicol., 69, 526-532.
30. Peruzzi, B., Araten, D. J., Notaro, R. and Luzzatto, L. (2010) The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Mutat. Res., 705, 3-10.
31. Schlegel, R. and MacGregor, J. T. (1984) The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fischer 344 rats: implications for cytogenetic screening. Mutat. Res., 127, 169-174.